As PIK3CA and AKT1 are the core components of PI3K-Akt signaling pathway, we speculate that the mechanism of MC participating in sarcopenia treatment may be through the regulation of PI3K-Akt signaling pathway, which also play crucial role in inflammaging [54]. The gene discussed is AKT1; the disease is sarcopenia.